Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.360
-0.170 (-4.82%)
Jan 21, 2026, 3:56 PM CET
Scandinavian ChemoTech AB Company Description
Scandinavian ChemoTech AB (publ) offers cancer care and pain management solutions in Sweden and Florida.
The company offers IQWave, an electroporation device, used for electrochemotherapy and treatment of head and neck cancer, squamous cell carcinoma, malignant melanoma, basal cell carcinoma, adenocarcinoma of the breast and salivary gland, hypernephroma, kaposi sarcoma, and transitional cell carcinoma.
It also offers Vetiqure for the treatment of superficial tumors in dogs, cats, and horses. The company markets its products through distribution channels and a network of human medicine opinion leaders in the Middle East, Asia, India, and Africa.
Scandinavian ChemoTech AB (publ) was incorporated in 2013 and is headquartered in Lund, Sweden.
Scandinavian ChemoTech AB (publ)
| Country | Sweden |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Stefan Frick |
Contact Details
Address: Medicon Village Lund, 223 63 Sweden | |
| Phone | 46 1 02 18 93 00 |
| Website | chemotech.se |
Stock Details
| Ticker Symbol | CMOTEC.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009242654 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stefan Mohan Frick | Founder, Chief Executive Officer, President and Director |
| Ann Ohlsson | Head of Finance |